Gaudium IVF & Women Health
add_icon

Gaudium IVF & Women Health

113.91
-2.31
(-1.99%)
Market Cap
829.12 Cr
PE Ratio
36.49
Volume
1,48,329.00
Day High - Low
117.90 - 112.60
52W High-Low
163.18 - 69.18
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
829.12 Cr
EPS
3.92
PE Ratio
36.49
PB Ratio
5.55
Book Value
20.92
EBITDA
37.71
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
41.31
Debt to Equity
0.52
Forecast For
Actual

Company News

View All News
Caret
neutral
Gaudium IVF and Women Health Limited has scheduled its 11th Annual General Meeting for September 28, 2026. The meeting will be conducted via Video Conferencing or Other Audio Visual Means. Shareholders can access the notice and annual report electronically.
negative
Gaudium IVF & Women Health reported a 42% YoY drop in consolidated net profit to ₹177.6 lakh for Q1FY27, driven by one-time marketing spends and hub setup costs.
positive
Gaudium IVF and Women Health Ltd commenced operations at a new IVF Centre/Hub in South Extension, New Delhi on July 16, 2026. The facility offers advanced fertility and reproductive healthcare services.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,914.30
#1 32,090.90
58.24
#1 2,864.20
12.11
#1 510
27.24
49.93
1,570.70
16,161.99
85.58
835.00
19.34
173
37.56
63.96
596.60
12,369.17
61.10
1,671.40
24.15
191
25.61
58.55
565.20
8,996.02
50.31
846.00
20.48
163
33.94
43.53
751.60
7,541.61
87.90
1,023.40
32.93
77
35.02
59.93
353.25
1,839.75
49.93
313.60
22.55
31
40.22
62.12
545.15
1,768.39
18.03
816.20
9.90
101
-19.51
44.36
1,375.60
1,180.63
20.24
141.92
27.17
61
-28.57
46.61
539.00
1,053.37
#1 14.28
498.80
#1 237.48
70
#1 45.92
46.80
297.50
946.36
-35.82
1,319.27
12.68
-3
-92.48
48.68

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
46.99 %
Net Income Growth
28.06 %
Cash Flow Change
153.49 %
ROE
-17.21 %
ROCE
-15.64 %
EBITDA Margin (Avg.)
-11.61 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
14
27
18
32
25
31
21
Expenses
9
18
13
18
18
18
17
EBITDA
6
9
5
14
7
12
4
Operating Profit %
39 %
32 %
29 %
43 %
27 %
40 %
13 %
Depreciation
1
0
1
1
1
1
1
Interest
0
0
1
1
1
1
0
Profit Before Tax
5
8
4
13
5
10
3
Tax
1
2
1
3
1
2
1
Net Profit
3
7
3
9
4
8
2
EPS in ₹
0.55
1.05
0.50
1.53
0.59
1.34
0.25

Balance Sheet

Balance Sheet
2022
2023
2024
2025
2026
Total Assets
18
37
57
89
193
Fixed Assets
4
18
19
18
29
Current Assets
14
18
38
54
73
Capital Work in Progress
0
0
0
7
0
Investments
0
0
0
5
4
Other Assets
14
18
39
58
0
Total Equity & Liabilities
18
37
57
89
193
Current Liabilities
6
10
20
38
39
Non Current Liabilities
3
4
4
4
2
Total Equity
9
23
33
46
152
Reserve & Surplus
8
22
32
16
116
Share Capital
1
1
1
31
36

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
14
-3
-5
Investing Activities
-1
-16
-5
-15
Operating Activities
-1
24
3
9
Financing Activities
3
5
-1
2

Share Holding

% Holding
Jan 2025
Sept 2025
Feb 2026
Mar 2026
Jun 2026
Promoter
99.98 %
99.98 %
71.29 %
71.29 %
71.29 %
FIIs
0.00 %
0.00 %
9.24 %
6.70 %
3.02 %
DIIs
0.00 %
0.00 %
5.11 %
2.62 %
2.22 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
13.52 %
14.67 %
16.78 %
Others
0.02 %
0.02 %
0.84 %
4.73 %
6.69 %
No of Share Holders
7
7
7
19,854
21,910

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Sept 2026 123.35 116.05
18 Mar 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
18 Mar 2026 81.09 85.00
28 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2026 116.74 116.79
13 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2026 132.50 123.35

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2026
Weblink Letter To Shareholders - Pursuant To Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 03, 2026
Reg. 34 (1) Annual Report.Sep 03, 2026
Notice Of 11Th Annual General Meeting Of The CompanySep 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 01, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 19, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 14, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 14, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 13, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 13, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 13, 2026
Statement Of Deviation & Variation For The Quarter Ended June 30 2026Aug 13, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementAug 13, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementAug 13, 2026
Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026Aug 13, 2026
Board Meeting Outcome for Board Meeting Outcome For Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026Aug 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2026
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2026.Aug 07, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 16, 2026
Intimation Under Regulation 30 And Para B Schedule III - Commencement Of Commercial Operations Of New IVF Centre/Hub At South Extension New DelhiJul 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 11, 2026
Closure of Trading WindowJun 26, 2026
Gaudium IVF And Women Health Limited Has Informed The Exchange About Corrigendum To The Financial Results Submitted For The Quarter And Year Ended March 31 2026Jun 25, 2026
Board Meeting Outcome for Approval For Setting Up Of Gaudium Women Hospital At Lucknow Uttar PradeshJun 25, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 08, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 29, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 29, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 29, 2026
Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026May 28, 2026
Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026May 28, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2026
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Audited Standalone And Consolidated Financial Statements/Results Of The Company For The Quarter And Year Ended March 31 2026.May 22, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
Clarification On Price MovementApr 16, 2026
Clarification sought from Gaudium IVF and Women Health LtdApr 16, 2026
Intimation Regarding Change Of Corporate Identification Number Of The CompanyApr 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Gaudium IVF And Women Health Limited Has Updated The Exchange On The Query Received From BSE Limited Vide Its Email Dated April 07 2026 Seeking Additional Details For Corporate Announcement Dated April 06 2026 Filed Under Regulation 30 Of SEBI (LODR) ReguApr 07, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Apr 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 01, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 ( "Listing Regulations")Apr 01, 2026
Closure of Trading WindowMar 28, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 19, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 19, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 18, 2026
Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Mar 18, 2026
Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Mar 18, 2026

Technical Indicators

RSI(14)
Neutral
45.07
ATR(14)
Less Volatile
6.12
STOCH(9,6)
Neutral
29.21
STOCH RSI(14)
Neutral
39.20
MACD(12,26)
Bullish
0.14
ADX(14)
Weak Trend
13.56
UO(9)
Bearish
35.06
ROC(12)
Downtrend And Accelerating
-9.00
WillR(14)
Neutral
-75.90